Please login to the form below
diagnostic testing
This page shows the latest diagnostic testing news and features for those working in and with pharma, biotech and healthcare.
LifeArc partners with UK Dementia Research Institute
A new partnership between LifeArc and the UK Dementia Research Institute (UK DRI) has been announced to accelerate the development of new diagnostic tests, treatments and devices to benefit people with ... The partnership will allow UK DRI scientists
Latest news
-
Speed kills
From testing to reopening to vetting scientific articles, we have lost track of time. ... Diagnostic and antibody testing has not been excluded from this obsession with velocity either.
-
Policy and public health COVID-19 by the numbers
The number of people who have tested positive worldwide. This is like the entire country of Latvia testing positive for the disease. ... Johns Hopkins University. 30%. The supposed number of false negatives that we obtain with diagnostic testing for COVID
-
FDA green lights rapid coronavirus diagnostic test
The approval of Cepheid’s test comes as criticism grows over how the US is handling its coronavirus testing strategy. ... The FDA has already approved another COVID-19 test from Roche, although this diagnostic only facilitates laboratory testing,
-
FDA okays Roche’s COVID-19 diagnostic test
Increases capacity for testing as coronavirus cases grow. The US Food and Drug Administration (FDA) has approved Roche’s diagnostic test for the novel coronavirus, authorising it for emergency use. ... CE marking indicates that an in vitro diagnostic
-
Roche Diagnostics among beneficiaries as NHS fast-tracks more tech
Twist says diagnostic testing accounts for 70% of clinical decisions, yet only makes up 1% of total NHS spend. ... At Roche, we have long called for mandated funding for NICE-approved diagnostic tests and we are delighted at this important step forward.
More from news
Approximately 1 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
Patient-centricity and how HCPs can help achieve better patient outcomes through collaboration
5. Rework – Genomics England is currently working on initiatives to ensure genetic testing is done correctly to reduce the need for patients to return for a second biopsy. ... 6. Over-production – unnecessary diagnostic testing is an area for waste
-
Rare diseases: why they can be so difficult to identify
That may have been quite some time ago, and many innovations have occurred since then in testing and diagnostic approaches. ... That clinician can provide insight throughout the diagnostic process, including advice on when to consider additional testing,
-
Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications
According to John McCarthy, Principal Consultant, DT Associates, and former VP Global Digital, AstraZeneca, “as medicines become more expensive, clinical utilisation will be more and more dependent on diagnostic testing or ... even generic testing.
-
Combining therapies and combining research
Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more effective vaccines, less use of antibiotics in agriculture, fast diagnostic testing, more professionals
-
The future of medicine has to be data-driven
Improved treatment options, organised screenings and the growing adoption of diagnostic testing are all factors associated with this development. ... The rapid adoption of genomic testing powered by AI in recent years illustrates the faith in this
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Atlas Genetics appoints Jeffery Luber as CEO
As diagnostic testing increasingly becomes more decentralised, I look forward to working with the team to make Atlas the leading global player in POC testing.”.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Can Artificial Intelligence Solve the Healthcare Crisis?
This upgrade could allow clinicians to detect heart failure faster and more reliably than current diagnostic testing, potentially having a huge positive impact on prognostic outcomes.
-
Blockchain in Healthcare: Predictions for the Post-COVID World
Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing.
-
Understanding COVID-19 and varying responses across the globe
Development of sensitive and specific diagnostic testing involves designing primers for assays and trialling serology assays that look at the immune response. ... However, rolling out national testing became a major challenge for many countries
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
To healthcare professionals (HCPs), a patient failing to benefit from drug treatment may require additional consultations, further diagnostic testing, or hospital admission.
-
Ansar Jawair discusses precision medicines - what they are, where we are today and their future
Some of the major challenges include working with the complexities in different countries, trying to establish diagnostic testing, for enabling precision medicine. ... Furthermore, through advances in precision medicines and in diagnostic testing, we are
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
